[PDF][PDF] Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review)[RETIRED] Report of the Quality Standards Subcommittee of …
GS Gronseth, RJ Barohn - Neurology, 2000 - AAN Enterprises
The Quality Standards Subcommittee of the American Academy of Neurology is charged
with developing practice parameters for neurologists for diagnostic procedures, treatment …
with developing practice parameters for neurologists for diagnostic procedures, treatment …
Clinical spectrum of chronic acquired demyelinating polyneuropathies
DS Saperstein, JS Katz, AA Amato… - Muscle & Nerve …, 2001 - Wiley Online Library
A number of presentations of chronic demyelinating polyneuropathy have been identified,
each distinguished by its phenotypic pattern. In addition to classic chronic inflammatory …
each distinguished by its phenotypic pattern. In addition to classic chronic inflammatory …
Guillain-Barré syndrome and variants
MM Dimachkie, RJ Barohn - Neurologic clinics, 2013 - neurologic.theclinics.com
Jean-Baptiste Octave Landry in 1859 1 first described a case of distal sensory “formications”
and ascending weakness after a prodromal fever, malaise, and pain who progressed to …
and ascending weakness after a prodromal fever, malaise, and pain who progressed to …
[PDF][PDF] 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory …
IE Lundberg, A Tjärnlund, M Bottai… - Arthritis & …, 2017 - Wiley Online Library
Objective To develop and validate new classification criteria for adult and juvenile idiopathic
inflammatory myopathies (IIM) and their major subgroups. Methods Candidate variables …
inflammatory myopathies (IIM) and their major subgroups. Methods Candidate variables …
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
PH Gordon, DH Moore, RG Miller, JM Florence… - The Lancet …, 2007 - thelancet.com
Background Minocycline has anti-apoptotic and anti-inflammatory effects in vitro, and
extends survival in mouse models of some neurological conditions. Several trials are …
extends survival in mouse models of some neurological conditions. Several trials are …
[HTML][HTML] Randomized trial of thymectomy in myasthenia gravis
GI Wolfe, HJ Kaminski, IB Aban… - … England Journal of …, 2016 - Mass Medical Soc
Background Thymectomy has been a mainstay in the treatment of myasthenia gravis, but
there is no conclusive evidence of its benefit. We conducted a multicenter, randomized trial …
there is no conclusive evidence of its benefit. We conducted a multicenter, randomized trial …
Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria
RJ Barohn, JT Kissel, JR Warmolts… - Archives of …, 1989 - jamanetwork.com
• Over a 10-year period, we followed up 60 patients (35 men and 25 women) with chronic
inflammatory demyelinating polyradiculoneuropathy. Diagnosis was based on previously …
inflammatory demyelinating polyradiculoneuropathy. Diagnosis was based on previously …
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double …
JF Howard, K Utsugisawa, M Benatar, H Murai… - The Lancet …, 2017 - thelancet.com
Background Complement is likely to have a role in refractory generalised myasthenia gravis,
but no approved therapies specifically target this system. Results from a phase 2 study …
but no approved therapies specifically target this system. Results from a phase 2 study …
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
Objective Myostatin is an endogenous negative regulator of muscle growth and a novel
target for muscle diseases. We conducted a safety trial of a neutralizing antibody to …
target for muscle diseases. We conducted a safety trial of a neutralizing antibody to …
Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis
SA Greenberg, JL Pinkus, GS Pinkus… - Annals of Neurology …, 2005 - Wiley Online Library
Dermatomyositis has been modeled as an autoimmune disease largely mediated by the
adaptive immune system, including a local humorally mediated response with B and T …
adaptive immune system, including a local humorally mediated response with B and T …